JP2025163212A5 - - Google Patents

Info

Publication number
JP2025163212A5
JP2025163212A5 JP2025131588A JP2025131588A JP2025163212A5 JP 2025163212 A5 JP2025163212 A5 JP 2025163212A5 JP 2025131588 A JP2025131588 A JP 2025131588A JP 2025131588 A JP2025131588 A JP 2025131588A JP 2025163212 A5 JP2025163212 A5 JP 2025163212A5
Authority
JP
Japan
Prior art keywords
composition according
compound
disorder
amphetamine
unconjugated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025131588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025163212A (ja
Filing date
Publication date
Priority claimed from US16/667,804 external-priority patent/US11136295B2/en
Application filed filed Critical
Publication of JP2025163212A publication Critical patent/JP2025163212A/ja
Publication of JP2025163212A5 publication Critical patent/JP2025163212A5/ja
Pending legal-status Critical Current

Links

JP2025131588A 2018-10-29 2025-08-06 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス Pending JP2025163212A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862752324P 2018-10-29 2018-10-29
US201962800494P 2019-02-02 2019-02-02
US16/667,804 US11136295B2 (en) 2018-10-29 2019-10-29 D-amphetamine compounds, compositions, and processes for making and using the same
US16/667,804 2019-10-29
PCT/US2020/019140 WO2021086426A1 (en) 2018-10-29 2020-02-21 D-amphetamine compounds, compositions, and processes for making and using the same
JP2022525742A JP7653428B2 (ja) 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024071955A JP7830540B2 (ja) 2018-10-29 2024-04-25 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2024071955A Division JP7830540B2 (ja) 2018-10-29 2024-04-25 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス

Publications (2)

Publication Number Publication Date
JP2025163212A JP2025163212A (ja) 2025-10-28
JP2025163212A5 true JP2025163212A5 (https=) 2026-04-01

Family

ID=70328134

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2022525745A Active JP7653429B2 (ja) 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2022525742A Active JP7653428B2 (ja) 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024071955A Active JP7830540B2 (ja) 2018-10-29 2024-04-25 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024208343A Pending JP2025023120A (ja) 2018-10-29 2024-11-29 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2025131588A Pending JP2025163212A (ja) 2018-10-29 2025-08-06 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2022525745A Active JP7653429B2 (ja) 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2022525742A Active JP7653428B2 (ja) 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024071955A Active JP7830540B2 (ja) 2018-10-29 2024-04-25 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024208343A Pending JP2025023120A (ja) 2018-10-29 2024-11-29 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス

Country Status (13)

Country Link
US (4) US11174229B2 (https=)
EP (2) EP4051268A4 (https=)
JP (5) JP7653429B2 (https=)
KR (3) KR20220088727A (https=)
CN (2) CN114746091A (https=)
AU (2) AU2020372736A1 (https=)
BR (2) BR112022008208A2 (https=)
CA (2) CA3158405A1 (https=)
IL (2) IL292496A (https=)
MX (2) MX2022005013A (https=)
PH (2) PH12022551047A1 (https=)
WO (2) WO2021086426A1 (https=)
ZA (2) ZA202204678B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11174229B2 (en) * 2018-10-29 2021-11-16 Kempharm, Inc. D-amphetamine compounds, compositions, and processes for making and using the same
CN120131637A (zh) * 2025-05-08 2025-06-13 中国人民解放军海军军医大学 左乙拉西坦在制备抗疲劳的药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504509A (ja) * 1987-08-07 1990-12-20 ジ・アップジョン・カンパニー 非ペプチド結合を有するレニン抑制ペプチド
DE4234012A1 (de) * 1992-10-09 1994-04-14 Basf Ag Neue Anilinderivate und diese enthaltende Pflanzenschutzmittel
AU1494702A (en) * 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
SI1644019T2 (en) 2003-05-29 2018-04-30 Shire Llc Abuse resistant amphetamine compounds
US8163701B2 (en) 2005-08-19 2012-04-24 Signature Therapeutics, Inc. Prodrugs of active agents
CA2763172A1 (en) 2009-05-26 2010-12-02 David Hackett Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
CA3123900A1 (en) * 2011-07-28 2013-01-31 Kempharm Inc. Methylphenidate-prodrugs, processes of making and using the same
BR102012004888A2 (pt) 2012-03-05 2013-10-22 Phartrials Pesquisas Farmaceuticas Ltda Associação de um derivado de sulfamato monossubstituído do monossacarídeo natural d-frutose (topiramato) com um anti-depressivo da classe das fenilcetonas (bupropiona) para tratamento de obesidade e das síndromes plurimetabólicas
US20140073589A1 (en) * 2012-06-27 2014-03-13 Shire Ag Amphetamine Prodrugs
AU2013326850B2 (en) * 2012-10-04 2017-09-21 Inhibikase Therapeutics, Inc. Novel compounds, their preparation and their uses
JP6621329B2 (ja) * 2012-10-05 2019-12-18 スファエラ ファーマ ピーティーイー リミテッド 新規化合物、それらの合成及びそれらの使用
ITUA20161706A1 (it) * 2016-03-15 2017-09-15 Cyanagen S R L Nuovi coloranti cumarinici e relativi coniugati
HUE067004T2 (hu) * 2016-12-11 2024-10-28 Zevra Therapeutics Inc Metilfenidát prodrogokat tartalmazó készítmények, eljárások azok elõállítására és felhasználására
US20200114014A1 (en) 2017-04-11 2020-04-16 John K. Thottathil Novel Alpha-Hydroxy Carboxylic Acid and Derivatives and Other GRAS-Based Amide and Imide Prodrugs of Amphetamine Compounds and Uses Thereof
US20200109117A1 (en) * 2018-10-02 2020-04-09 ACCESS Association Modified Therapeutic Agent Analogs of Mefenamic Acid
US11174229B2 (en) * 2018-10-29 2021-11-16 Kempharm, Inc. D-amphetamine compounds, compositions, and processes for making and using the same

Similar Documents

Publication Publication Date Title
JP2025163212A5 (https=)
JP2025013344A5 (https=)
TWI598098B (zh) 脂質異常症治療劑
AU2019236666B2 (en) Aminocarbonylcarbamate compounds
JP2010519216A (ja) Ｃｃｒ５拮抗薬のための医薬組成物および方法
HRP20240748T1 (hr) Pripravci koji sadrže prolijekove metilfenidata, postupci za pripremu i uporabe istih
JP2018199719A5 (https=)
JP2022552881A5 (https=)
JP2024095711A (ja) 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール
JP2013506004A5 (https=)
US20240398762A1 (en) Pharmaceutical composition with analgesic and/or antipruritic functions and application thereof
US20230218562A1 (en) Aminocarbonylcarbamate compounds
JP2023501967A5 (https=)
JP2023501968A5 (https=)
US10874659B2 (en) Iloperidone metabolite for use in the treatment of psychiatric disorders
RU2017123161A (ru) Бензойная кислота, производные бензойной кислоты и конъюгаты гетероарилкарбоновой кислоты и оксиморфона, их пролекарства, способы получения и применение
JP7369185B2 (ja) カルバメート化合物の糖尿病性末梢神経障害又は化学療法剤誘発性末梢神経障害の予防、緩和又は治療のための使用
US20070123555A1 (en) Prevention and treatment of hearing disorders
US20160022675A1 (en) Processes for preparing tetrahydroisoquinolines
NZ787387A (en) D-amphetamine compounds, compositions, and processes for making and using the same
NZ787387B2 (en) D-amphetamine compounds, compositions, and processes for making and using the same
TWI227135B (en) Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions
JP2023509186A5 (https=)
US8716350B2 (en) Compositions and methods for the treatment of somatosensory disorders
JP4433496B2 (ja) Ａｔｐクエン酸リアーゼの発現抑制用医薬組成物及びその使用